Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FTWM2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,229
Award facts
- Contract value 100% obligated
- $19,228.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,228.84 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron HCl 4 mg tablets (30-count packages). This firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed in Conshohocken, Pennsylvania. The award carries no set-aside designation, allowing the vendor to compete on a full and open basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc., a pharmaceutical wholesaler based in Park Ridge, Illinois, is executing this delivery order under its existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. This umbrella IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities. Ondansetron is an anti-nausea medication commonly used in medical settings, and this delivery order represents one of many pharmaceutical product distributions the vendor provides to support federal healthcare operations and military medical facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FTWM2?
SPE2DB25FTWM2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWM2 worth?
The government has obligated $19,229 on SPE2DB25FTWM2.
Is contract SPE2DB25FTWM2 an order under another contract?
Yes. SPE2DB25FTWM2 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWM2 competed?
The extent of competition for SPE2DB25FTWM2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award